159 related articles for article (PubMed ID: 22511696)
1. Evaluating the relationship between carisoprodol concentrations and meprobamate formation and inter-subject and intra-subject variability in urinary excretion data of pain patients.
Tse SA; Atayee RS; Best BM; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):221-31. PubMed ID: 22511696
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data.
Barakat NH; Atayee RS; Best BM; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):257-64. PubMed ID: 22511700
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting carisoprodol metabolism in pain patients using urinary excretion data.
Tse SA; Atayee RS; Ma JD; Best BM
J Anal Toxicol; 2014 Apr; 38(3):122-8. PubMed ID: 24488112
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Slawson MH; Johnson-Davis KL
Methods Mol Biol; 2016; 1383():105-14. PubMed ID: 26660179
[TBL] [Abstract][Full Text] [Related]
5. Determination of carisoprodol and meprobamate in oral fluid.
Coulter C; Garnier M; Tuyay J; Orbita J; Moore C
J Anal Toxicol; 2012 Apr; 36(3):217-20. PubMed ID: 22417839
[TBL] [Abstract][Full Text] [Related]
6. Validation of a new homogeneous immunoassay for the detection of carisoprodol in urine.
Wang G; Huynh K; Barhate R; Rodrigues W; Moore C; Coulter C; Vincent M; Soares J
J Anal Toxicol; 2011 Mar; 35(2):108-12. PubMed ID: 21396230
[TBL] [Abstract][Full Text] [Related]
7. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution.
McIntyre IM; Sherrard J; Lucas J
J Anal Toxicol; 2012 Apr; 36(3):177-81. PubMed ID: 22417833
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults.
Lewandowski TA
Hum Exp Toxicol; 2017 Aug; 36(8):846-853. PubMed ID: 27758843
[TBL] [Abstract][Full Text] [Related]
9. A rapid quantitative method of carisoprodol and meprobamate by liquid chromatography-tandem mass spectrometry.
Essler S; Bruns K; Frontz M; McCutcheon JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():155-60. PubMed ID: 23040985
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the relationship of methadone concentrations and EDDP formation in chronic pain patients.
Leimanis E; Best BM; Atayee RS; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):239-49. PubMed ID: 22511698
[TBL] [Abstract][Full Text] [Related]
11. Transfer of carisoprodol to breast milk.
Nordeng H; Zahlsen K; Spigset O
Ther Drug Monit; 2001 Jun; 23(3):298-300. PubMed ID: 11360042
[TBL] [Abstract][Full Text] [Related]
12. Observations on the metabolism of morphine to hydromorphone in pain patients.
Hughes MM; Atayee RS; Best BM; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):250-6. PubMed ID: 22511699
[TBL] [Abstract][Full Text] [Related]
13. Formation of meprobamate from carisoprodol is catalysed by CYP2C19.
Dalén P; Alvan G; Wakelkamp M; Olsen H
Pharmacogenetics; 1996 Oct; 6(5):387-94. PubMed ID: 8946470
[TBL] [Abstract][Full Text] [Related]
14. Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.
Carbonaro TM; Nguyen V; Forster MJ; Gatch MB; Prokai L
Neuropharmacology; 2020 Sep; 174():108152. PubMed ID: 32479814
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of carisoprodol and acetaminophen in an attempted suicide by liquid chromatography-mass spectrometry with positive electrospray ionization.
Matsumoto T; Sano T; Matsuoka T; Aoki M; Maeno Y; Nagao M
J Anal Toxicol; 2003 Mar; 27(2):118-22. PubMed ID: 12670008
[TBL] [Abstract][Full Text] [Related]
16. Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.
Yee DA; Best BM; Atayee RS; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):232-8. PubMed ID: 22511697
[TBL] [Abstract][Full Text] [Related]
17. A one-step and sensitive GC-MS assay for meprobamate determination in emergency situations.
Daval S; Richard D; Souweine B; Eschalier A; Coudore F
J Anal Toxicol; 2006 Jun; 30(5):302-5. PubMed ID: 16839465
[TBL] [Abstract][Full Text] [Related]
18. Carisoprodol elimination in humans.
Olsen H; Koppang E; Alvan G; Mørland J
Ther Drug Monit; 1994 Aug; 16(4):337-40. PubMed ID: 7974621
[TBL] [Abstract][Full Text] [Related]
19. NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice.
Chan PC
Toxic Rep Ser; 2000 Aug; (56):1-G14. PubMed ID: 11986679
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of carisoprodol and meprobamate in whole blood using benzylcarbamate and deuterated meprobamate as internal standards.
Downey D; Simons K; Ota K; Kerrigan S
J Anal Toxicol; 2009 Jun; 33(5):278-82. PubMed ID: 19671248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
